An introduction to genetic and epigenetic changes in prostate gland – implications in efficacy of phytotherapy of benign prostatic hyperplasia and prostate cancer
The usage of classical pharmacological treatment of prostate diseases causes the risk of a number of side effects therefore the researchers are looking for new pharmacologically active molecules, including those contained in the plant extracts. The most widely studied is the lipido-sterolic extract...
Main Authors: | Joanna Bartkowiak-Wieczorek, Radosław Kujawski, Anna Bogacz, Marcin Ożarowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Poznan University of Medical Sciences
2015-06-01
|
Series: | Journal of Medical Science |
Subjects: | |
Online Access: | https://jms.ump.edu.pl/index.php/JMS/article/view/23 |
Similar Items
-
PHYTOTHERAPY FOR INFLAMMATORY DISEASES OF THE PROSTATE
by: N. G. Kulchenko, et al.
Published: (2019-09-01) -
Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
by: Argirović Aleksandar, et al.
Published: (2013-01-01) -
The efficacy of procin-x and celloid-s in the management of benign prostatic enlargement
by: K H Tijani, et al.
Published: (2014-01-01) -
Effects of Serenoa Repens, Selenium and Lycopene (Profluss®) on chronic inflammation associated with Benign Prostatic Hyperplasia: results of “FLOG” (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study
by: Giuseppe Morgia, et al.
Published: (2013-04-01) -
Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
by: Stéphane Terry, et al.
Published: (2013-07-01)